DISCERN™ Featured on Bloom TV: Advancing Early Alzheimer’s Diagnosis

We’re excited to share that SynapsDx CEO, Paul Tanico, recently appeared on Bloom TV with host Gayle Guyardo to discuss DISCERN™, our groundbreaking skin test for Alzheimer’s disease.

During the interview, Paul highlighted how DISCERN™ is changing the way Alzheimer’s is diagnosed:

• Delivering early, accurate answers with over 95% accuracy
• Differentiating Alzheimer’s from other, sometimes reversible, causes of dementia
• Enabling families to plan treatment, care, and next steps while the patient can still participate
• Leveraging more than 30 years of NIH-funded research, with findings confirmed by autopsy studies

Alzheimer’s diagnosis has long been a challenge, with many patients facing uncertainty and delayed answers. DISCERN™ provides the clarity families need to make informed decisions when it matters most.

📺 Watch the full interview here: https://www.wfla.com/bloom-tampa-bay/a-groundbreaking-skin-test-may-help-detect-alzheimers-early-and-accurately/

‍🌐 Learn more about DISCERN™: www.discerntest.com

‍